SEC Form 4 · accession 0001012975-15-000330
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mark J Levin
10% Owner
Robert I Tepper
10% Owner
Kevin P Starr
10% Owner
Third Rock Ventures II, L.P.
10% Owner
Third Rock Ventures GP II, L.P.
10% Owner
TRV GP II, LLC
10% Owner
Period of report
May 5, 2015
Accepted (ET)
May 12, 2015 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 5, 2015 | C | 5,454,545 | — | A | 5,727,272 | D | |
| Common StockF1,F2 | May 5, 2015 | C | 1,424,242 | — | A | 7,151,514 | D | |
| Common StockF1,F2 | May 5, 2015 | C | 241,545 | — | A | 7,393,059 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1 | — | May 5, 2015 | C | 30,000,000 | D | — | — | Common Stock | 5,454,545 | 0 | D |
| Series B Preferred StockF1 | — | May 5, 2015 | C | 7,833,333 | D | — | — | Common Stock | 1,424,242 | 0 | D |
| Series C Preferred StockF1 | — | May 5, 2015 | C | 1,328,502 | D | — | — | Common Stock | 241,545 | 0 | D |
Explanation of responses
- F1On May 5, 2015, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into Common Stock on a 5.5-for-1 basis for no additional consideration. The Preferred Stock had no expiration date.
- F2The shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II LP"). The general partner of TRV GP II LP is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper") and, as such, each of TRV GP II LP and TRV GP II LLC, Levin, Starr and Tepper exercises shared voting and investment power over the shares held of record by TRV II. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.